Ten years survival results of randomized study comparing weekly vs. triweekly cisplatin with concurrent radiation in locally advanced carcinoma cervix

BACKGROUND: The current standard of treatment for locally advanced cervical cancer is concurrent chemo-radiation with improved overall survival (OS) by 6% with manageable toxicities. The cisplatin 40 mg/m(2) given weekly is the widely practiced regimen for 4–6 cycles concurrently with irradiation. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanda, R, Katke, Aradhana, Thejaswini, B, Giri, GV, Pawar, Yashwant, Manjula, MV, Babu, Govind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547408/
https://www.ncbi.nlm.nih.gov/pubmed/37795405
http://dx.doi.org/10.5603/RPOR.a2023.0031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547408/
https://www.ncbi.nlm.nih.gov/pubmed/37795405
http://dx.doi.org/10.5603/RPOR.a2023.0031

Ejemplares similares